Antibacterial agents: New routes to tuberculosis treatment
Nature Reviews Drug Discovery 16, 600 (2017).
doi:10.1038/nrd.2017.156
Author: Sarah Crunkhorn
Treatment of drug-resistant strains of Mycobacterium tuberculosis is lengthy, involving the use of costly and less effective second-line drugs that exhibit substantial side effects. Two new papers now report the identification of novel agents that inhibit previously untargeted essential M. tuberculosis enzymes and
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Sarah Crunkhorn Tags: Research Highlight Source Type: research
More News: Drugs & Pharmacology | Tuberculosis